India Stock Highlights Today: Axis Bank, Reliance Industries, ONGC, M&M, ICICI Bank, Asian Paints, SBI, HUL, L&T, Titan, Infosys and TCS were among the top losers

India Stock Market Highlights Today: ONGC followed by Tata Steel, L&T, Sun Pharma, M&M, ICICI Bank and NTPC were among the top gainers in the Sensex pack

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) sought additional safety and efficacy data for COVID-19 vaccine candidates of Bharat Biotech after deliberating upon its applications seeking emergency use authorisation for the shots

VK Paul says globally, 33 vaccines are in clinical trial phase, of which 10 vaccines are in advanced trial phase. Key consideration while prioritising population for vaccine inoculation is accessing people with risk to mortality and protection of healthcare system and response system

Coronavirus in India: Active COVID-19 caseload continues to stay below 4 lakh for the seventh consecutive day

David Prior says next three months are going to be extremely difficult and the world is pinning hopes on vaccine; Serum Institute also hopes to get approval for emergency use in India soon after nod in the UK

Adar Poonawalla said that the health ministry is planning to vaccinate 20-30 per cent of India's population to reach a critical mass. He added that once 20 per cent of India gets the vaccine, confidence and sentiments are likely to come back

In a blog post, the vice-president of YouTube, Debbie Weinstein said: \"We're launching a new control in ad settings, enabling people to see fewer alcohol ads, with gambling as an additional option.\"

AstraZeneca's vaccine has an average efficacy of 70.4 per cent, according to data published in a journal. Russia, meanwhile, has said that Sputnik V is 92 per cent effective

The regulatory approval in the UK is crucial to strengthen SII's application seeking emergency use authorisation in India because the proposal here refers to trials being conducted in the UK and Brazil

India Stock Market Highlights Today: During the session, Sensex hit an all-time high of 46,309 and Nifty too logged a record high of 13,579

Head of the consumer health watchdog, Anna Popova, told the Komsomolskaya Pravda radio station on Tuesday that people should stop drinking alcohol at least two weeks before getting the first of the two injections

Managing Director Suneeta Reddy said that they want to know if the government will handle the entire thing alone or would involve the private sector

The Subject Expert Committee (SEC), a government panel tasked with vetting coronavirus vaccines, has asked Bharat Biotech and Serum Institute of India (SII) to submit updated country-specific trial data of their vaccine candidates Covaxin and Covishield

India Stock Market Highlights Today: UltraTech Cement followed by Tata Steel, ONGC, IndusInd Bank, HDFC Bank, M&M, Infosys and Reliance Industries were among the top losers in the Sensex pack. On the other hand, Maruti, Nestle India, Titan and PowerGrid were among the gainers

The government has recently raised hopes of billions of Indians as it came closer  to announcing that the vaccine  is on its way. Three COVID-19 vaccines candidates, developed by Bharat Biotech, Serum Institute of India and Pfizer, are under active consideration of India's drug regulator and there is hope that early licensure is possible for all or any of them, said the Union health ministry. The expert panel will meet today to review the application of drug makers. Watch the video for more details.  

Several experts have raised questions about Bharat Biotech applying for emergency usage as Covaxin is still going through an efficacy trial. However, the ICMR has backed Bharat Biotech's move

Union Health Ministry informed that the current cold chain system in India consists of 85,634 equipments for storage of vaccine at about 28,947 cold chain points across the country

Reliance Industries Ltd (RIL) chairman Mukesh Ambani said at the Indian Mobile Congress today, that the Indian economy will bounce back from the COVID-19 pandemic induced blow and prove cynics, who doubt the country's growth story, wrong by becoming a $5 trillion economy. Ambani said that the economy will not only rebound but will also grow \"with unprecedented acceleration.\" Watch the video for more details.

Margaret Keenan, a 90-year-old grandmother from Britain, has become the first person in the world to receive the Pfizer COVID-19 vaccine outside of a trial following its rapid clinical approval. An early riser, Keenan received the jab at her local hospital in Coventry, Central England, on Tuesday morning at 0631 GMT, a week before she turns 91. \"I feel so privileged to be the first person vaccinated against Covid-19,\" said Keenan. Watch the video for more details.